Global Newborn Screening Market to reach USD 1.4 billion by 2027.

Global Newborn Screening Market Size study, by Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, Other Technologies), by Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), Other Test Types), by End user (Hospitals, Diagnostic Centers, Other End Users) and Regional Forecasts 2021-2027
Product Code:  HALMD_98993916
Chapter 1.Executive Summary 
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Newborn Screening Market , by Region, 2019-2027 (USD Billion)
1.2.2. Newborn Screening Market , by   Technology, 2019-2027 (USD Billion)
1.2.3. Newborn Screening Market , by   Test Type, 2019-2027 (USD Billion)
1.2.4. Newborn Screening Market , by   End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Newborn Screening Market  Definition and Scope 
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Newborn Screening Market  Dynamics 
3.1. Newborn Screening Market Impact Analysis (2019-2027)
3.1.1. Market Drivers Rising prevalence of newborn disorders  Favourable reimbursement policies  
3.1.2. Market Restraint  Availability of refurbished products  
3.1.3. Market Opportunities Growth potential of emerging economies  
Chapter 4. Global Newborn Screening Market  Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political 
4.2.2. Economical
4.2.3. Social 
4.2.4. Technological 
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Newborn Screening Market , by   Technology
5.1. Market Snapshot 
5.2. Global Newborn Screening Market  by  Technology , Performance - Potential Analysis
5.3. Global Newborn Screening Market  Estimates & Forecasts by  Technology  2018-2027 (USD Billion)
5.4. Newborn Screening Market , Sub Segment Analysis
5.4.1. Tandem Mass Spectrometry
5.4.2. Pulse Oximetry
5.4.3. Enzyme Based Assays
5.4.4. DNA Assays
5.4.5. Other Technologies
Chapter 6. Global Newborn Screening Market , by   Test Type
6.1. Market Snapshot 
6.2. Global Newborn Screening Market  by  Test Type, Performance - Potential Analysis
6.3. Global Newborn Screening Market  Estimates & Forecasts by   Test Type    2018-2027 (USD Billion)
6.4. Newborn Screening Market , Sub Segment Analysis
6.4.1. Dried Blood Spot
6.4.2. Hearing Screening
6.4.3. Critical Congenital Heart Defect (CCHD)
6.4.4. Other Test Types
Chapter 7. Global Newborn Screening Market , by   End user
7.1. Market Snapshot 
7.2. Global Newborn Screening Market  by   End user, Performance - Potential Analysis
7.3. Global Newborn Screening Market  Estimates & Forecasts by   End user  2018-2027 (USD Billion)
7.4. Newborn Screening Market , Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Diagnostic Centers
7.4.3. Other End Users
Chapter 8. Global Newborn Screening Market , Regional Analysis
8.1. Newborn Screening Market , Regional Market Snapshot 
8.2. North America Newborn Screening Market  
8.2.1. U.S. Newborn Screening Market Technology breakdown estimates & forecasts, 2018-2027 Test Type breakdown estimates & forecasts, 2018-2027 End user breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Newborn Screening Market 
8.3. Europe Newborn Screening Market  Snapshot
8.3.1. U.K. Newborn Screening Market  
8.3.2. Germany Newborn Screening Market 
8.3.3. France Newborn Screening Market 
8.3.4. Spain Newborn Screening Market 
8.3.5. Italy Newborn Screening Market 
8.3.6. Rest of Europe Newborn Screening Market 
8.4. Asia-Pacific Newborn Screening Market  Snapshot
8.4.1. China Newborn Screening Market  
8.4.2. India Newborn Screening Market  
8.4.3. Japan Newborn Screening Market 
8.4.4. Australia Newborn Screening Market 
8.4.5. South Korea Newborn Screening Market 
8.4.6. Rest of Asia Pacific Newborn Screening Market 
8.5. Latin America Newborn Screening Market  Snapshot
8.5.1. Brazil Newborn Screening Market 
8.5.2. Mexico Newborn Screening Market 
8.6. Rest of The World Newborn Screening Market 
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bio-Rad Laboratories Inc.   Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. GE Healthcare                   
9.2.3. Masimo Corporation               
9.2.4. Medtronic Inc.                 
9.2.5. Natus Medical Incorporated                  
9.2.6. PerkinElmer Inc.                   
9.2.7. Trivitron Healthcare                  
9.2.8.  ZenTech SA                  
9.2.9. Waters Corporation  
9.2.10.  Thermo Fisher Scientific   

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

Global Newborn Screening Market is valued at approximately USD 0.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 % over the forecast period 2021-2027. In recent years, the prevalence of fetal diseases has increased, leading healthcare providers to raise awareness and promote the need for innovative screening tools. The most common newborn defects are hearing, metabolic, and hormonal disorders, as well as critical congenital heart disease, all of which are treatable if detected early. According to the US CDC, the prevalence of newborn diseases in the United States was 34 per 10,000 live births between 2015 and 2017. Per year, about 12,900 babies are predicted to be diagnosed with a condition. Hearing deficiency (16.5 per 10,000), congenital hypothyroidism (6.0 per 10,000), sickle-cell disease (4.9 per 10,000), and cystic fibrosis are some other common diseases, according to the same source (1.8 per 10,000). Similarly, congenital heart disease affects 9 out of every 1,000 children, overall 200,000 children a year, according to the Indian Pediatric Academy. Due to their high birth rates and rising disposable income, India, China, and Brazil provide major opportunities to players. According to the United Nations Children’s Fund, India has 25 million births per year, accounting for almost one-fifth of all births worldwide. Because of the high birth rate and the provision of newborn screening in public hospitals, market products and consumables are in high demand. However, the availability of refurbished products may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Newborn Screening Market is considered for the key regions such as Asia Pacific, Europe, North America, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to availability of newborn screening programs, favorable reimbursement policies, and a strong market player presence in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to increasing screening rate, and rising awareness regarding early diagnosis across APAC.

Major market player included in this report are:

Bio-Rad Laboratories Inc.
GE Healthcare
Masimo Corporation
Medtronic Inc.
Natus Medical Incorporated
PerkinElmer Inc.
Trivitron Healthcare
ZenTech SA
Waters Corporation
Thermo Fisher Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assays
DNA Assays
Other Technologies
By Test Type:
Dried Blood Spot
Hearing Screening
Critical Congenital Heart Defect (CCHD)
Other Test Types
By End user:
Diagnostic Centers
Other End Users
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.

Target Audience of the Global Newborn Screening Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.